PLoS ONE:研究人员发现尼古丁减轻吸烟者焦虑的机制

2013-05-06 Beyond 生物谷

近日,一项临床前数据表明一个特定烟碱受体的失活可能是一种有效的策略来帮助烟民戒烟,同时又不会让戒烟者感到焦虑,相关研究由弗吉尼亚联邦大学研究人员领导完成。 这些发现可能有一天帮助研究人员开发出新的疗法帮助吸烟者戒烟。烟民吸烟的原因有很多,但许多报告认为吸烟可以缓解焦虑,尽管吸烟会健康危害。 在这项发表在PLoS ONE杂志上的研究论文中,研究人员发现低剂量的尼古丁可以发挥烟碱受体阻滞剂类似的影

近日,一项临床前数据表明一个特定烟碱受体的失活可能是一种有效的策略来帮助烟民戒烟,同时又不会让戒烟者感到焦虑,相关研究由弗吉尼亚联邦大学研究人员领导完成。

这些发现可能有一天帮助研究人员开发出新的疗法帮助吸烟者戒烟。烟民吸烟的原因有很多,但许多报告认为吸烟可以缓解焦虑,尽管吸烟会健康危害。

在这项发表在PLoS ONE杂志上的研究论文中,研究人员发现低剂量的尼古丁可以发挥烟碱受体阻滞剂类似的影响,都可以在动物模型中降低焦虑样行为。他们发现,一个特定的烟碱受体失活,可以减轻焦虑,该受体主要结合尼古丁的β2亚基。

药理学和毒理学系博士Darlene Brunzell说:这项研究表明,尼古丁可通过灭活,而不是激活高亲和力的烟碱受体。尼古丁的作用像一把钥匙,打开(激活)大脑中尼古丁受体。研究结果表明低剂量的尼古丁可能会阻断调节焦虑行为的特定受体亚型。

Brunzell和他的同事们正在进行研究希望确定哪些脑区域调节尼古丁的抗焦虑作用。从治疗角度来看,确定是否阻断β2亚型烟碱受体可以解除吸烟者焦虑将是非常重要的。

doi:10.1371/journal.pone.0048665
PMC:
PMID:

Low Dose Nicotine and Antagonism of β2 Subunit Containing Nicotinic Acetylcholine Receptors Have Similar Effects on Affective Behavior in Mice

Shawn M. Anderson, Darlene H. Brunzell

Nicotine leads to both activation and desensitization (inactivation) of nicotinic acetylcholine receptors (nAChRs). This study tested the hypothesis that nicotine and a selective antagonist of β2*nAChRs would have similar effects on affective behavior. Adult C57BL/6J male mice were tested in a conditioned emotional response (CER) assay which evaluates the ability of an aversive stimulus to inhibit goal-directed behavior. Mice lever-pressed for a saccharin reinforcer according to a variable schedule of reinforcement during sessions in which two presentations of a compound light/tone conditioned stimulus (CS) co-terminated with a 0.1 or 0.3 mA, 0.5 s footshock unconditioned stimulus (US). During testing in the absence of the US, mice received doses of i.p. nicotine (0, 0.0032, 0.01, 0.032, 0.1 mg/kg) or a selective β2 subunit containing nAChR (β2*nAChR) antagonist dihydro-beta-erythroidine (0, 0.1, 0.3, 1.0, 3.0 mg/kg DHβE). There was a dose-dependent effect of nicotine revealing that only low doses (0.01, 0.032 mg/kg) increased CER suppression ratios (SR) in these mice. DHβE also dose-dependently increased SR at the 3 mg/kg dose. In ethological measures of fear?/anxiety-like behavior, these doses of nicotine and DHβE significantly reduced digging behavior in a marble burying task and 0.3 mg/kg DHβE promoted open-arm activity in the elevated plus maze. Doses of nicotine and DHβE that altered affective behavior had no effect on locomotor activity. Similar to previous reports with anxiolytic drugs, low dose nicotine and DHβE reversed SR in a CER assay, decreased digging in a marble burying assay and increased open arm activity in the elevated plus maze. This study provides evidence that inactivation of β2*nAChRs reduces fear-like and anxiety-like behavior in rodents and suggests that smokers may be motivated to smoke in part to desensitize their β2*nAChRs. These data further identify β2*nAChR antagonism as a potential therapeutic strategy for relief of negative affect and anxiety.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1907419, encodeId=7881190e41943, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Thu Aug 29 10:56:00 CST 2013, time=2013-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789519, encodeId=8d491e8951942, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Wed May 29 16:56:00 CST 2013, time=2013-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605074, encodeId=913416050e42e, content=<a href='/topic/show?id=5cba39435fd' target=_blank style='color:#2F92EE;'>#吸烟者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39435, encryptionId=5cba39435fd, topicName=吸烟者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc8619318136, createdName=124984e7m89暂无昵称, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1907419, encodeId=7881190e41943, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Thu Aug 29 10:56:00 CST 2013, time=2013-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789519, encodeId=8d491e8951942, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Wed May 29 16:56:00 CST 2013, time=2013-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605074, encodeId=913416050e42e, content=<a href='/topic/show?id=5cba39435fd' target=_blank style='color:#2F92EE;'>#吸烟者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39435, encryptionId=5cba39435fd, topicName=吸烟者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc8619318136, createdName=124984e7m89暂无昵称, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1907419, encodeId=7881190e41943, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Thu Aug 29 10:56:00 CST 2013, time=2013-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789519, encodeId=8d491e8951942, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Wed May 29 16:56:00 CST 2013, time=2013-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605074, encodeId=913416050e42e, content=<a href='/topic/show?id=5cba39435fd' target=_blank style='color:#2F92EE;'>#吸烟者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39435, encryptionId=5cba39435fd, topicName=吸烟者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc8619318136, createdName=124984e7m89暂无昵称, createdTime=Wed May 08 14:56:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]

相关资讯

Neurology:尼古丁或可防治老年人慢性记忆功能减退

2012年1月10日,美国神经病学会医学杂志Neurology刊登的一项关于尼古丁治疗慢性记忆功能减退的文章"Nicotine treatment of mild cognitive impairment A 6-month double-blind pilot clinical trial"证实,尼古丁贴片可以改善老年患者慢性记忆功能减退。 尼古丁已经被证实可以改善已戒烟者的认知功能。同时以往

Sci Transl Med:基因疗法能治愈尼古丁成瘾吗?

一项刊登在Science Translational Medicine上新的研究报告说,一种抗尼古丁抗体的基因疗法可阻止尼古丁进入脑部,并可能成为一个治疗吸烟成瘾的新的疗法。当吸烟者吸烟的时候,尼古丁会跨经肺部并在几秒钟内进入血流。这种成瘾性的药物会找到其进入脑子的途径并附着在奖励受体之上并引发快感,而这种快感会驱使吸烟者点燃另外一根香烟。科学家们最近一直在探索一种抗尼古丁疫苗的理念,这种疫苗可阻

Neuropsychopharmacol:新药物作用大脑多巴胺受体抑制尼古丁上瘾

意大利Aptuit中心研究人员发现,一种名为GSK598809的实验性药物能够阻断大脑中一种多巴胺受体,该多巴胺受体以被证实与尼古丁上瘾有关。 研究小组考察药物对狒狒和小鼠的影响,相关研究论文发表在Neuropsychopharmacology杂志上,当该药物传递到大脑时,这种药物能够减少对尼古丁的渴望。 与大多数成瘾机制类似,尼古丁可与尼古丁乙酰胆碱接受器结果,增加神经传递物的量,脑中的多巴

Nat med:尼古丁促腹主动脉瘤形成

  腹主动脉瘤(abdominal aortic aneurysm,AAA)是主动脉瘤最常见的形式。破裂的腹主动脉瘤是导致美国人口死亡的第13位因素。目前引起AAA的确切原因并不清楚。在所有可识别的风险因子中,吸烟能够增加患AAA 风险7.6倍,并且是唯一一个与AAA发展、扩张以及破裂相关的可改变因素。但是吸烟增加AAA的机制目前还不清楚。   AAAs的病理特征为

Addiction Bio:吸烟或影响睡眠质量

德国一项最新调查则发现,吸烟者的睡眠时间比不吸烟者少,而且睡眠质量也较差。 睡眠问题多 研究人员对1071名吸烟者做关于睡眠质量的问卷调查,结果显示,其中17%每晚睡眠时间不足6小时,28%称睡眠质量“受到干扰”、较易浅眠。另对1243名不吸烟者所做的同样调查中,上述数据分别为7%和19%。调查对象均无精神病史。 正常情况下,人每晚会有4至5个深睡、浅睡和快速动眼(REM)睡眠的睡眠周期。较